187 related articles for article (PubMed ID: 14599357)
1. Development of a 1-microl scale assay for mitogen-activated kinase kinase 7 using 2-D fluorescence intensity distribution analysis anisotropy.
Wright PA; Boyd HF; Bethell RC; Busch M; Gribbon P; Kraemer J; Lopez-Calle E; Mander TH; Winkler D; Benson N
J Biomol Screen; 2002 Oct; 7(5):419-28. PubMed ID: 14599357
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence polarization competition immunoassay for tyrosine kinases.
Seethala R
Methods; 2000 Sep; 22(1):61-70. PubMed ID: 11020319
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.
Johnson GL; Lapadat R
Science; 2002 Dec; 298(5600):1911-2. PubMed ID: 12471242
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-linked immunosorbent assay for the measurement of JNK activity in cell extracts.
Tamaskovic R; Forrer P; Jaussi R
Biol Chem; 1999 May; 380(5):569-78. PubMed ID: 10384963
[TBL] [Abstract][Full Text] [Related]
5. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
6. Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format.
Klumpp M; Boettcher A; Becker D; Meder G; Blank J; Leder L; Forstner M; Ottl J; Mayr LM
J Biomol Screen; 2006 Sep; 11(6):617-33. PubMed ID: 16760365
[TBL] [Abstract][Full Text] [Related]
7. Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase.
Adler V; Pincus MR
Ann Clin Lab Sci; 2004; 34(1):35-46. PubMed ID: 15038666
[TBL] [Abstract][Full Text] [Related]
8. A direct ELISA assay for quantitative determination of the inhibitory potency of small molecules inhibitors for JNK3.
Goettert M; Luik S; Graeser R; Laufer SA
J Pharm Biomed Anal; 2011 Apr; 55(1):236-40. PubMed ID: 21316174
[TBL] [Abstract][Full Text] [Related]
9. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
10. A flow-through fluorescence polarization detection system for measuring GPCR-mediated modulation of cAMP production.
Kool J; van Marle A; Hulscher S; Selman M; van Iperen DJ; van Altena K; Gillard M; Bakker RA; Irth H; Leurs R; Vermeulen NP
J Biomol Screen; 2007 Dec; 12(8):1074-83. PubMed ID: 18087072
[TBL] [Abstract][Full Text] [Related]
11. A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases.
Gaudet EA; Huang KS; Zhang Y; Huang W; Mark D; Sportsman JR
J Biomol Screen; 2003 Apr; 8(2):164-75. PubMed ID: 12844437
[TBL] [Abstract][Full Text] [Related]
12. Development of a fluorescence polarization bead-based coupled assay to target different activity/conformation states of a protein kinase.
Lu Z; Yin Z; James L; Syto R; Stafford JM; Koseoglu S; Mayhood T; Myers J; Windsor W; Kirschmeier P; Samatar AA; Malcolm B; Turek-Etienne TC; Kumar CC
J Biomol Screen; 2004 Jun; 9(4):309-21. PubMed ID: 15191648
[TBL] [Abstract][Full Text] [Related]
13. Early identification of false positives in high-throughput screening for activators of p53-DNA interaction.
Wölcke J; Hunt N; Jungmann J; Ullmann D
J Biomol Screen; 2006 Jun; 11(4):341-50. PubMed ID: 16751330
[TBL] [Abstract][Full Text] [Related]
14. Development of a microplate-based, electrophoretic fluorescent protein kinase a assay: comparison with filter-binding and fluorescence polarization assay formats.
Miick SM; Jalali S; Dwyer BP; Havens J; Thomas D; Jimenez MA; Simpson MT; Zile B; Huss KL; Campbell RM
J Biomol Screen; 2005 Jun; 10(4):329-38. PubMed ID: 15964934
[TBL] [Abstract][Full Text] [Related]
15. Two simple and generic antibody-independent kinase assays: comparison of a bioluminescent and a microfluidic assay format.
Pommereau A; Pap E; Kannt A
J Biomol Screen; 2004 Aug; 9(5):409-16. PubMed ID: 15296640
[TBL] [Abstract][Full Text] [Related]
16. Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.
Harris A; Cox S; Burns D; Norey C
J Biomol Screen; 2003 Aug; 8(4):410-20. PubMed ID: 14567793
[TBL] [Abstract][Full Text] [Related]
17. Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors.
Hubert CL; Sherling SE; Johnston PA; Stancato LF
J Biomol Screen; 2003 Aug; 8(4):399-409. PubMed ID: 14567792
[TBL] [Abstract][Full Text] [Related]
18. Utilization of fluorescence polarization and time resolved fluorescence resonance energy transfer assay formats for SAR studies: Src kinase as a model system.
Newman M; Josiah S
J Biomol Screen; 2004 Sep; 9(6):525-32. PubMed ID: 15452339
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence polarization is a useful technology for reagent reduction in assay miniaturization.
Kowski TJ; Wu JJ
Comb Chem High Throughput Screen; 2000 Oct; 3(5):437-44. PubMed ID: 11032959
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of fluorescence polarization and lifetime discriminated polarization for high throughput screening of serine/threonine kinases.
Fowler A; Swift D; Longman E; Acornley A; Hemsley P; Murray D; Unitt J; Dale I; Sullivan E; Coldwell M
Anal Biochem; 2002 Sep; 308(2):223-31. PubMed ID: 12419333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
